203 related articles for article (PubMed ID: 37456256)
1. A non-mutated
Guerra E; Di Pietro R; Stati G; Alberti S
Front Oncol; 2023; 13():1151090. PubMed ID: 37456256
[TBL] [Abstract][Full Text] [Related]
2. The Trop-2 signalling network in cancer growth.
Guerra E; Trerotola M; Aloisi AL; Tripaldi R; Vacca G; La Sorda R; Lattanzio R; Piantelli M; Alberti S
Oncogene; 2013 Mar; 32(12):1594-600. PubMed ID: 22562244
[TBL] [Abstract][Full Text] [Related]
3. A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.
Guerra E; Trerotola M; Dell' Arciprete R; Bonasera V; Palombo B; El-Sewedy T; Ciccimarra T; Crescenzi C; Lorenzini F; Rossi C; Vacca G; Lattanzio R; Piantelli M; Alberti S
Cancer Res; 2008 Oct; 68(19):8113-21. PubMed ID: 18829570
[TBL] [Abstract][Full Text] [Related]
4. High levels of expression of Trop-2 in thymic epithelial tumors.
Yeung V; Zaemes J; Yeh J; Giancarlo C; Ahn J; Reuss JE; Kallakury BV; Liu SV; Duttargi A; Khan G; Kim C
Lung Cancer; 2023 Oct; 184():107324. PubMed ID: 37573703
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Trop-2 quantitatively stimulates human cancer growth.
Trerotola M; Cantanelli P; Guerra E; Tripaldi R; Aloisi AL; Bonasera V; Lattanzio R; de Lange R; Weidle UH; Piantelli M; Alberti S
Oncogene; 2013 Jan; 32(2):222-33. PubMed ID: 22349828
[TBL] [Abstract][Full Text] [Related]
6. Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.
Wang J; Zhang K; Grabowska D; Li A; Dong Y; Day R; Humphrey P; Lewis J; Kladney RD; Arbeit JM; Weber JD; Chung CH; Michel LS
Mol Cancer Res; 2011 Dec; 9(12):1686-95. PubMed ID: 21970857
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway.
Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X
PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649
[TBL] [Abstract][Full Text] [Related]
8. Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer.
Guerra E; Trerotola M; Relli V; Lattanzio R; Tripaldi R; Vacca G; Ceci M; Boujnah K; Garbo V; Moschella A; Zappacosta R; Simeone P; de Lange R; Weidle UH; Rotelli MT; Picciariello A; Depalo R; Querzoli P; Pedriali M; Bianchini E; Angelucci D; Pizzicannella G; Di Loreto C; Piantelli M; Antolini L; Sun XF; Altomare DF; Alberti S
Neoplasia; 2021 Sep; 23(9):898-911. PubMed ID: 34320447
[TBL] [Abstract][Full Text] [Related]
9. The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target.
Shen M; Liu S; Stoyanova T
Am J Clin Exp Urol; 2021; 9(1):73-87. PubMed ID: 33816696
[TBL] [Abstract][Full Text] [Related]
10. Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2.
El Sewedy T; Fornaro M; Alberti S
Int J Cancer; 1998 Jan; 75(2):324-30. PubMed ID: 9462726
[TBL] [Abstract][Full Text] [Related]
11. Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas?
Akarken İ; Dere Y
Ann Diagn Pathol; 2021 Feb; 50():151680. PubMed ID: 33341704
[TBL] [Abstract][Full Text] [Related]
12. Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas.
Fornaro M; Dell'Arciprete R; Stella M; Bucci C; Nutini M; Capri MG; Alberti S
Int J Cancer; 1995 Sep; 62(5):610-8. PubMed ID: 7665234
[TBL] [Abstract][Full Text] [Related]
13. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
Lin JC; Wu YY; Wu JY; Lin TC; Wu CT; Chang YL; Jou YS; Hong TM; Yang PC
EMBO Mol Med; 2012 Jun; 4(6):472-85. PubMed ID: 22419550
[TBL] [Abstract][Full Text] [Related]
14. Trop2: Jack of All Trades, Master of None.
Lenárt S; Lenárt P; Šmarda J; Remšík J; Souček K; Beneš P
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187148
[TBL] [Abstract][Full Text] [Related]
15. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.
Cubas R; Zhang S; Li M; Chen C; Yao Q
Mol Cancer; 2010 Sep; 9():253. PubMed ID: 20858281
[TBL] [Abstract][Full Text] [Related]
16. v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1.
Ju X; Jiao X; Ertel A; Casimiro MC; Di Sante G; Deng S; Li Z; Di Rocco A; Zhan T; Hawkins A; Stoyanova T; Andò S; Fatatis A; Lisanti MP; Gomella LG; Languino LR; Pestell RG
Cancer Res; 2016 Nov; 76(22):6723-6734. PubMed ID: 27634768
[TBL] [Abstract][Full Text] [Related]
17. Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
Guan H; Guo Z; Liang W; Li H; Wei G; Xu L; Xiao H; Li Y
BMC Cancer; 2017 Jul; 17(1):486. PubMed ID: 28709407
[TBL] [Abstract][Full Text] [Related]
18. Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.
Yip-Schneider MT; Lin A; Barnard D; Sweeney CJ; Marshall MS
Int J Oncol; 1999 Aug; 15(2):271-9. PubMed ID: 10402237
[TBL] [Abstract][Full Text] [Related]
19. Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma.
Bobos M; Kotoula V; Kaloutsi V; Karayannopoulou G; Papadimitriou CS; Kostopoulos I
Histol Histopathol; 2009 Aug; 24(8):1035-48. PubMed ID: 19554511
[TBL] [Abstract][Full Text] [Related]
20. Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.
Hsu EC; Rice MA; Bermudez A; Marques FJG; Aslan M; Liu S; Ghoochani A; Zhang CA; Chen YS; Zlitni A; Kumar S; Nolley R; Habte F; Shen M; Koul K; Peehl DM; Zoubeidi A; Gambhir SS; Kunder CA; Pitteri SJ; Brooks JD; Stoyanova T
Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2032-2042. PubMed ID: 31932422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
